Review





Similar Products

kinases alk  (Carna Inc)
95
Carna Inc kinases alk
Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for <t>ALK</t> ( B <t>),</t> <t>MET</t> ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.
Kinases Alk, supplied by Carna Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinases+alk/bio_rxiv__2025__07__04__663216-187-1-15?v=Carna+Inc
Average 95 stars, based on 1 article reviews
kinases alk - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
alk anaplastic lymphoma kinase hhv8 herpes virus 8 qiime quantitative insights  (Biotechnology Information)
86
Biotechnology Information alk anaplastic lymphoma kinase hhv8 herpes virus 8 qiime quantitative insights
Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for <t>ALK</t> ( B <t>),</t> <t>MET</t> ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.
Alk Anaplastic Lymphoma Kinase Hhv8 Herpes Virus 8 Qiime Quantitative Insights, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinases+alk/pm41375040-223-0-32?v=Biotechnology+Information
Average 86 stars, based on 1 article reviews
alk anaplastic lymphoma kinase hhv8 herpes virus 8 qiime quantitative insights - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
kinase 3 alk 3  (R&D Systems)
93
R&D Systems kinase 3 alk 3
Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for <t>ALK</t> ( B <t>),</t> <t>MET</t> ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.
Kinase 3 Alk 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinases+alk/10__3390_slash_pr13113395-91-10-20?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
kinase 3 alk 3 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
anaplastic lymphoma kinase alk  (Abbott Laboratories)
86
Abbott Laboratories anaplastic lymphoma kinase alk
Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for <t>ALK</t> ( B <t>),</t> <t>MET</t> ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.
Anaplastic Lymphoma Kinase Alk, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinases+alk/fda_document____cdrh_docs_slash_pdf11_slash_p110012b-0-19-18?v=Abbott+Laboratories
Average 86 stars, based on 1 article reviews
anaplastic lymphoma kinase alk - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
alk tyrosine kinase inhibitor  (Pfizer Inc)
86
Pfizer Inc alk tyrosine kinase inhibitor
Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for <t>ALK</t> ( B <t>),</t> <t>MET</t> ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.
Alk Tyrosine Kinase Inhibitor, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinases+alk/fda_document____drugsatfda_docs_slash_nda_slash_2018_slash_210868orig1s000multidiscipliner-2247-9-18?v=Pfizer+Inc
Average 86 stars, based on 1 article reviews
alk tyrosine kinase inhibitor - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
monoclonal antibodies to anaplastic lymphoma kinase–1 (alk–1)  (Thermo Fisher)
90
Thermo Fisher monoclonal antibodies to anaplastic lymphoma kinase–1 (alk–1)
Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for <t>ALK</t> ( B <t>),</t> <t>MET</t> ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.
Monoclonal Antibodies To Anaplastic Lymphoma Kinase–1 (Alk–1), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinases+alk/pmc12185445-50-97-101?v=Thermo+Fisher
Average 90 stars, based on 1 article reviews
monoclonal antibodies to anaplastic lymphoma kinase–1 (alk–1) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
anaplastic lymphoma kinase (alk) rabbit antibody  (Beyotime)
90
Beyotime anaplastic lymphoma kinase (alk) rabbit antibody
Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for <t>ALK</t> ( B <t>),</t> <t>MET</t> ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.
Anaplastic Lymphoma Kinase (Alk) Rabbit Antibody, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinases+alk/pmc11995683-84-25-8?v=Beyotime
Average 90 stars, based on 1 article reviews
anaplastic lymphoma kinase (alk) rabbit antibody - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
molecule kinase inhibitors  (MedChemExpress)
94
MedChemExpress molecule kinase inhibitors
Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for <t>ALK</t> ( B <t>),</t> <t>MET</t> ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.
Molecule Kinase Inhibitors, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinases+alk/pm40106350-244-6-9?v=MedChemExpress
Average 94 stars, based on 1 article reviews
molecule kinase inhibitors - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
kinase gene alk  (Kirstein GmbH)
90
Kirstein GmbH kinase gene alk
Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for <t>ALK</t> ( B <t>),</t> <t>MET</t> ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.
Kinase Gene Alk, supplied by Kirstein GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinases+alk/pm40351161-215-19-2?v=Kirstein+GmbH
Average 90 stars, based on 1 article reviews
kinase gene alk - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
alk-tyrosine kinase inhibitors (tkis)  (Firstline Biopharmaceuticals Corporation)
90
Firstline Biopharmaceuticals Corporation alk-tyrosine kinase inhibitors (tkis)
Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for <t>ALK</t> ( B <t>),</t> <t>MET</t> ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.
Alk Tyrosine Kinase Inhibitors (Tkis), supplied by Firstline Biopharmaceuticals Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinases+alk/pm40119140-22-0-15?v=Firstline+Biopharmaceuticals+Corporation
Average 90 stars, based on 1 article reviews
alk-tyrosine kinase inhibitors (tkis) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for ALK ( B ), MET ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.

Journal: bioRxiv

Article Title: A Computational Workflow for Structure-Guided Design of Potent and Selective Kinase Peptide Substrates

doi: 10.1101/2025.07.04.663216

Figure Lengend Snippet: Experimental validation of designed peptides shows improved kinase activity. ( A ) ADP-Glo assay baseline measurements showing kinase activity with parental substrates and background controls for all five tested kinases. ( B–F ) Relative percentage change in kinase activity for designed peptides compared to parental substrates for ALK ( B ), MET ( C ), ROS1 ( D ), EGFR L858R ( E ), and SRC ( F ). Designed peptides are color-coded with sequence information provided. Phosphosite residues that were fixed during design are highlighted in green. Four out of five kinases showed substantial activity improvements with at least one designed peptide.

Article Snippet: The kinases ALK (#08-518), MET (#08-151), ROS1 (#08-163), and EGFR L858R (#08-502) were products of Carna Biosciences.

Techniques: Biomarker Discovery, Activity Assay, Glo Assay, Sequencing, Phospho-proteomics

Kinetic characterization reveals improved binding affinity of designed peptides. ( A ) Schematic of kinase phosphorylation reaction monitored by the LIMS-kinase assay. ( B ) Multiple reaction monitoring (MRM) setup showing the mass spectrometry detection pathway for ADP quantification. ( C–E ) Michaelis-Menten kinetic analysis comparing parental and optimized peptides for ROS1 ( C ), MET ( D ), and ALK ( E ). Left panels show time-course data at varying substrate concentrations; right panels show saturation curves with fitted K m values and 95% confidence intervals. The designed peptides demonstrated lower K m values, indicating improved apparent binding affinity.

Journal: bioRxiv

Article Title: A Computational Workflow for Structure-Guided Design of Potent and Selective Kinase Peptide Substrates

doi: 10.1101/2025.07.04.663216

Figure Lengend Snippet: Kinetic characterization reveals improved binding affinity of designed peptides. ( A ) Schematic of kinase phosphorylation reaction monitored by the LIMS-kinase assay. ( B ) Multiple reaction monitoring (MRM) setup showing the mass spectrometry detection pathway for ADP quantification. ( C–E ) Michaelis-Menten kinetic analysis comparing parental and optimized peptides for ROS1 ( C ), MET ( D ), and ALK ( E ). Left panels show time-course data at varying substrate concentrations; right panels show saturation curves with fitted K m values and 95% confidence intervals. The designed peptides demonstrated lower K m values, indicating improved apparent binding affinity.

Article Snippet: The kinases ALK (#08-518), MET (#08-151), ROS1 (#08-163), and EGFR L858R (#08-502) were products of Carna Biosciences.

Techniques: Binding Assay, Phospho-proteomics, Kinase Assay, Targeted Proteomics, Mass Spectrometry

Structural analysis reveals molecular basis for improved activity. ( A-D ) Comparison of AlphaFold-Multimer predicted structures and hydrogen bonding networks for parental (green) versus designed (yellow) peptides in complex with ALK ( A ), ROS1 ( B ), MET ( C ), and EGFR L858R ( D ). Kinase structures are shown in gray ribbon representation. Green boxes highlight hydrogen bond interactions formed by parental peptides; yellow boxes show interactions formed by designed peptides. Designed peptides generally form additional or optimized hydrogen bonds that correlate with improved experimental activity.

Journal: bioRxiv

Article Title: A Computational Workflow for Structure-Guided Design of Potent and Selective Kinase Peptide Substrates

doi: 10.1101/2025.07.04.663216

Figure Lengend Snippet: Structural analysis reveals molecular basis for improved activity. ( A-D ) Comparison of AlphaFold-Multimer predicted structures and hydrogen bonding networks for parental (green) versus designed (yellow) peptides in complex with ALK ( A ), ROS1 ( B ), MET ( C ), and EGFR L858R ( D ). Kinase structures are shown in gray ribbon representation. Green boxes highlight hydrogen bond interactions formed by parental peptides; yellow boxes show interactions formed by designed peptides. Designed peptides generally form additional or optimized hydrogen bonds that correlate with improved experimental activity.

Article Snippet: The kinases ALK (#08-518), MET (#08-151), ROS1 (#08-163), and EGFR L858R (#08-502) were products of Carna Biosciences.

Techniques: Activity Assay, Comparison